Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 2
1(33.3%)
Phase 3
1(33.3%)
3Total
N/A(1)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00132548Phase 3Completed

A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children

Role: collaborator

NCT00132561Phase 2Completed

A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children

Role: collaborator

NCT01454752Not ApplicableCompleted

Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and Cognition

Role: collaborator

NCT01545115Completed

Study of the Environmental Factors Modulating Children Immune Response in Northern Senegal

Role: collaborator

All 4 trials loaded